Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
editorial
. 2013 Jul 9;17(2):73–75. doi: 10.1007/BF00200039

Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?

B M Vose 1,✉
PMCID: PMC11039290  PMID: 6235911

The content is available as a PDF (373.0 KB).

References

  • 1.Cheever MA, Greenberg PD, Fefer A, Gillis S. Augmentation of the anti-tumour therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified Interleukin-2. J Exp Med. 1982;155:968. doi: 10.1084/jem.155.4.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Csako G, Binder RA, Kales AN, Neefe JR. Cloning of human lymphocytes reactive with autologous leukemia cells. Cancer Res. 1980;40:3218. [PubMed] [Google Scholar]
  • 3.Dennert G, Yogeeswaran G, Yamagata S. Cloned cell lines with natural killer activity. J Exp Med. 1981;153:545. doi: 10.1084/jem.153.3.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.DeVries JE, Spits H. Cloned human cytotoxic T lymphcyte (CTL) lines reactive with autologous melanoma cells. J Immunol. 1984;132:510. [PubMed] [Google Scholar]
  • 5.Fossati G, Balsari A, Taramelli D, Sensi ML, Pellegris G, Nava M, Parmiani G. Lysis of autologous human melanoma cells by in vitro allosensitised peripheral blood lymphocytes. Cancer Immunol Immunother. 1982;14:99. doi: 10.1007/BF00200176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Grimm EA, Mazumder A, Zhang Z, Rosenberg SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by Interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982;155:1823. doi: 10.1084/jem.155.6.1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes and natural killer cells. J Exp Med. 1983;157:884. doi: 10.1084/jem.157.3.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hercend T, Meuer S, Reinherz EL, Schlossman SF, Ritz J. Generation of a cloned NK cell line derived from the “null cell” fraction of human peripheral blood. J Immunol. 1982;129:1299. [PubMed] [Google Scholar]
  • 9.Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with Interleukin-2. Int J Cancer. 1981;28:695. doi: 10.1002/ijc.2910280607. [DOI] [PubMed] [Google Scholar]
  • 10.Kimber I, Moore M. Naturally cytotoxic tonsillar lymphocytes: a manifestation of heterogeneity among human NK cells. Scand J Immunol. 1983;17:29. doi: 10.1111/j.1365-3083.1983.tb00762.x. [DOI] [PubMed] [Google Scholar]
  • 11.Mazumder A, Rosenberg SA. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by Interleukin-2. J Exp Med. 1984;159:495. doi: 10.1084/jem.159.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA. Lysis of fresh human solid tumours by autologous lymphocytes activated in vitro with lectins. Cancer Res. 1982;41:913. [PubMed] [Google Scholar]
  • 13.Mazumder A, Grimm EA, Rosenberg SA. Lysis of fresh human solid tumour cells by autologous lymphocytes activated in vitro by allosensitisation. Cancer Immunol Immunother. 1983;15:1. doi: 10.1007/BF00199454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Moore M, Taylor GM, White WJ. Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes. Cancer Immunol Immunother. 1982;13:56. doi: 10.1007/BF00200202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mukherji B, MacAlister TJ. Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med. 1983;158:240. doi: 10.1084/jem.158.1.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ortaldo JR, Timonen TT, Vose BM, Alvarez JA. Human natural killer cells as well as T cells maintained in continuous cultures with IL-2. In: Fefer A, Goldstein A, editors. The potential role of T cells in cancer therapy. New York: Raven Press; 1982. p. 191. [Google Scholar]
  • 17.Pawelec GP, Hadam MR, Schneider M, Wernet P. Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines. J Immunol. 1982;129:2271. [PubMed] [Google Scholar]
  • 18.Serrate SA, Vose BM, Timonen T, Ortaldo JR, Herberman RB. Association of human natural killer cell activity against human primary tumours with large granular lymphocytes. In: Herberman RB, editor. NL cells and other natural effector cells. New York: Academic Press; 1982. p. 1055. [Google Scholar]
  • 19.Strausser JL, Mazumder A, Grimm EA, Lotze MT, Rosenberg SA. Lysis of human solid tumours by autologous cells sensitised in vitro to alloantigens. J Immunol. 1981;127:266. [PubMed] [Google Scholar]
  • 20.Vanky F, Klein E. Specificity of auto-tumour cytotoxicity exerted by fresh, activated and propagated human T lymphocytes. Int J Cancer. 1982;29:547. doi: 10.1002/ijc.2910290510. [DOI] [PubMed] [Google Scholar]
  • 21.Vanky F, Argov S, Einhorn S, Klein E. The role of alloantigens in natural killing. Allogeneic but not autologous tumour biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphocytes. J Exp Med. 1980;151:1151. doi: 10.1084/jem.151.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vanky F, Gorsky T, Gorsky Y, Masucci M-G, Klein E. Lysis of tumour biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. J Exp Med. 1982;155:83. doi: 10.1084/jem.155.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Vose BM. Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. Int J Cancer. 1982;30:135. doi: 10.1002/ijc.2910300202. [DOI] [PubMed] [Google Scholar]
  • 24.Vose BM, Bonnard GD. In: Limiting dilution analysis of the precursor cells capable of specific cytotoxic or proliferative responses to human tumour cells and their expansion with lectin-free interleukin-2. Serrou B, editor. Amsterdam: Elsevier Biomedical Press; 1982. p. 385. [Google Scholar]
  • 25.Vose BM, Bonnard GD. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin-2. J Immunol. 1983;130:687. [PubMed] [Google Scholar]
  • 26.Vose BM, Moore M. Natural cytotoxicity in humans: susceptibility of freshly isolated tumour cells to lysis. JNCI. 1980;65:257. [PubMed] [Google Scholar]
  • 27.Vose BM, Moore M. Cultured human T-cell lines kill autologous solid tumours. Immunol Lett. 1981;3:237. doi: 10.1016/0165-2478(81)90081-X. [DOI] [PubMed] [Google Scholar]
  • 28.Vose BM, White W. Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Cancer Immunol Immunother. 1983;15:227. doi: 10.1007/BF00199170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Vose BM, Riccardi C, Marchmont RJ, Bonnard GD. Clonal analysis of human natural killer cells. In: Herberman RB, editor. NK cells and other natural effector cells. New York: Academic Press; 1982. p. 879. [Google Scholar]
  • 30.Zagury D, Morgan D, Lenoir G, Fouchard M, Feldman M. Human normal CTL clones: Generation and properties. Int J Cancer. 1983;31:427. doi: 10.1002/ijc.2910310406. [DOI] [PubMed] [Google Scholar]
  • 31.Zarling JM, Raich PC, McKeough M, Bach FH. Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature. 1976;262:691. doi: 10.1038/262691a0. [DOI] [PubMed] [Google Scholar]
  • 32.Zarling JM, Kay NE, Grant B, Yasukawa M, Bach FH. Human antilymphoma responses generated in vitro and in vivo following sensitisation with allogeneic leukocytes. Cancer Immunol Immunother. 1983;15:237. doi: 10.1007/BF00199171. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES